Welcome to our dedicated page for Heartbeam news (Ticker: BEAT), a resource for investors and traders seeking the latest updates and insights on Heartbeam stock.
HeartBeam, Inc. develops medical technology for ambulatory cardiac monitoring, centered on a patented cable-free 3D ECG platform that captures signals from three non-coplanar dimensions and synthesizes a 12-lead ECG. News commonly covers the FDA-cleared HeartBeam System for arrhythmia assessment, limited commercial launch activity, preventive cardiology and concierge practice deployments, AI-ECG collaboration, and development of on-demand patch and heart attack detection initiatives.
Corporate updates also include financial results and common-stock financing used to support commercialization, product development, AI capabilities, working capital, and general corporate purposes.
BioTelemetry, Inc. (NASDAQ: BEAT) will announce its second quarter 2020 earnings on July 30 at 4:00 PM ET, followed by a conference call at 5:00 PM ET. The call will be accessible via the investor section of the BioTelemetry website. The company, a leader in remote medical technology, offers services including remote cardiac monitoring and centralized laboratory services for clinical trials. This announcement may set expectations for the company’s financial performance ahead of the earnings release.
Summary not available.
Summary not available.